Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Tania Lobo"'
Autor:
Caroline Jackman, Jon F Pennycuff, Colleen McGuire, Kristi D. Graves, Ami Chitalia, Felice Yang, Tania Lobo
Publikováno v:
Cancer Research. 81:PS9-26
Introduction: Approximately 25% of women in the United States experience a symptomatic pelvic floor disorder such as urinary incontinence, pelvic organ prolapse, anal incontinence, and sexual dysfunction. Aspects associated with breast cancer treatme
Autor:
Eric D. Anderson, Shelby Fallon, Rafael Meza, Brady McKee, Jennifer L Stephens, Tania Lobo, Michael Ramsaier, Cassandra A. Stanton, Emily Kim, Jinani Jayasekera, Judith Howell, David B. Abrams, Ellen A. Dornelas, Juan C Batlle, George Luta, Danielle E. Deros, Kimberly Davis, Vicky Parikh, Kathryn L. Taylor, Raymond Niaura
Publikováno v:
Contemporary Clinical Trials. 82:25-35
Lung cancer mortality can be reduced by 20% via low dose CT lung cancer screening (LCS) and treatment of early-stage disease. Providing tobacco use treatment to high risk cigarette smokers in the LCS setting may result in health benefits beyond the i
Autor:
Amethyst Leimpeter, David S. Aaronson, Stephen K. Van Den Eeden, Kathryn L. Taylor, George Luta, Richard M. Hoffman, David F. Penson, Kimberly Davis, Tania Lobo
Publikováno v:
Med Decis Making
Background. Men with a low-risk prostate cancer (PCa) should consider observation, particularly active surveillance (AS), a monitoring strategy that avoids active treatment (AT) in the absence of disease progression. Objective. To determine clinical
Autor:
Amethyst Leimpeter, Stephen K. Van Den Eeden, Kathryn L. Taylor, Richard M. Hoffman, Kimberly Davis, Yingjun Zhou, Tania Lobo, Jun Shan, Roxanne E. Jensen, David S. Aaronson, George Luta
Publikováno v:
Translational Behavioral Medicine. 8:156-165
As many as 40% of men diagnosed with prostate cancer have low-risk disease, which results in the need to decide whether to undergo active treatment (AT) or active surveillance (AS). The treatment decision can have a significant effect on general and
Autor:
Tania Lobo, Ashley Wilder Smith, David Thissen, George Luta, Carol M. Moinpour, Bryce B. Reeve, Jaeil Ahn, David Cella, Elizabeth A. Hahn, Roxanne E. Jensen, Arnold L. Potosky
Publikováno v:
Journal of Clinical Oncology. 35:1913-1920
Purpose To estimate cancer population-based reference values in the United States for eight PROMIS (Patient-Reported Outcomes Measurement Information System) domains by age and stage of disease. Patients and Methods For the Measuring Your Health (MY-
Autor:
Tania Lobo, Jun Shan, David S. Aaronson, Amethyst D. Leimpter, Stephen K. Van Den Eeden, Kathryn L. Taylor, Richard M. Hoffman, George Luta, Arnold L. Potosky, Scott P. Kelly
Publikováno v:
Journal of Urology. 196:734-740
We determined the clinical and sociodemographic predictors of beginning active treatment in an ethnically diverse population of men with low risk prostate cancer initially on observational treatment.We retrospectively studied men diagnosed with low r
Autor:
Julia Friberg, Louis M. Weiner, Chul Kim, Mara Tynan, Kellie Gardner, Mary Chris Ponder, Waseem Ahmed, Deepa S. Subramaniam, Lisa Cusaac, Emily Russell, Kimberly Davis, Tania Lobo, Jillian Thompson, Kathryn L. Taylor, Chan To, Kenneth P. Tercyak, Shelby Fallon
Publikováno v:
J Cancer Surviv
PURPOSE. It is well-established that persistent tobacco use among patients with cancer results in numerous adverse outcomes. However, the assessment and treatment of tobacco use with evidence-based methods has been lacking in cancer care. Our cancer
Autor:
Kathryn L. Taylor, Amy J. Starosta, Charlotte J. Hagerman, Stephen K. Van Den Eeden, George Luta, Richard M. Hoffman, David S. Aaronson, Scott P. Kelly, Amethyst Leimpeter, Tania Lobo, Kimberly Davis, Jun Shan, Catherine Tomko
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:1240-1250
Background: Due to the concerns about the overtreatment of low-risk prostate cancer, active surveillance (AS) is now a recommended alternative to the active treatments (AT) of surgery and radiotherapy. However, AS is not widely utilized, partially du
Autor:
Bola F. Ekezue, Tania Lobo, Marc Schwartz, Huei-Ting Tsai, Nandini Selvam, Suzanne C. O'Neill, Claudine Isaacs, Calvin Chao, Arnold L. Potosky, Larry Kessler, Chunfu Liu
Publikováno v:
Journal of the National Comprehensive Cancer Network. 13:1216-1224
BACKGROUND A number of practice guidelines incorporate the use of gene expression profiling (GEP) tests for early-stage, hormone receptor-positive, HER2-negative breast tumors. Few studies describe factors associated with GEP testing in US oncology p
Autor:
Yun-Ling Zheng, Brittany McKinnon, Yvonne Jennings, Dennis Tolsma, Ying Wang, Mahlet G. Tadesse, Martha Trout, Hanfei Xu, Alejandra Hurtado-de-Mendoza, Kristi D. Graves, Vanessa B. Sheppard, Brandi Robinson, Tania Lobo
Publikováno v:
Journal of cancer survivorship : research and practice. 12(1)
Advances in precision medicine (PM) have potential to reduce and/or eliminate breast cancer disparities in both treatment and survivorship. However, compared to white Americans, black Americans are often underrepresented in genetic research. This rep